cyclo(tyrosyl-tyrosyl) has been researched along with rifampin in 2 studies
| Studies (cyclo(tyrosyl-tyrosyl)) | Trials (cyclo(tyrosyl-tyrosyl)) | Recent Studies (post-2010) (cyclo(tyrosyl-tyrosyl)) | Studies (rifampin) | Trials (rifampin) | Recent Studies (post-2010) (rifampin) |
|---|---|---|---|---|---|
| 7 | 0 | 4 | 20,468 | 1,499 | 6,552 |
| Protein | Taxonomy | cyclo(tyrosyl-tyrosyl) (IC50) | rifampin (IC50) |
|---|---|---|---|
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.949 | |
| Caspase-1 | Homo sapiens (human) | 8.319 | |
| Alpha-synuclein | Homo sapiens (human) | 7.1 | |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | Mycobacterium tuberculosis H37Rv | 0.03 | |
| DNA-directed RNA polymerase subunit beta | Mycobacterium tuberculosis H37Rv | 0.01 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 1.5 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abell, C; Blankley, RT; Campbell, B; Charoensutthivarakul, S; Coyne, AG; de Carvalho, LPS; Evangelopoulos, D; Frederickson, M; Katariya, MM; Kavanagh, ME; Levy, CW; Leys, D; McLean, KJ; Munro, AW; Selvam, IR; Tunnicliffe, RB | 1 |
| Alshabani, LA; Bhakta, S; Estrada, DF; Kumar, A; Simons, C; Srithiran, G; Willcocks, SJ | 1 |
2 other study(ies) available for cyclo(tyrosyl-tyrosyl) and rifampin
| Article | Year |
|---|---|
A new strategy for hit generation: Novel in cellulo active inhibitors of CYP121A1 from Mycobacterium tuberculosis via a combined X-ray crystallographic and phenotypic screening approach (XP screen).
Topics: Antitubercular Agents; Drug Design; Humans; Mycobacterium tuberculosis; Tuberculosis; X-Rays | 2022 |
Synthesis, biological evaluation and computational studies of pyrazole derivatives as
Topics: | 2022 |